Kinase drug discovery 20 years after imatinib: progress and future directions. Cohen, P., Cross, D., & Jänne, P. A. Nature Reviews Drug Discovery, 20(7):551–569, July, 2021. Number: 7 Publisher: Nature Publishing Group![Kinase drug discovery 20 years after imatinib: progress and future directions [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Protein kinases regulate nearly all aspects of cell life, and alterations in their expression, or mutations in their genes, cause cancer and other diseases. Here, we review the remarkable progress made over the past 20 years in improving the potency and specificity of small-molecule inhibitors of protein and lipid kinases, resulting in the approval of more than 70 new drugs since imatinib was approved in 2001. These compounds have had a significant impact on the way in which we now treat cancers and non-cancerous conditions. We discuss how the challenge of drug resistance to kinase inhibitors is being met and the future of kinase drug discovery.
@article{cohen_kinase_2021,
title = {Kinase drug discovery 20 years after imatinib: progress and future directions},
volume = {20},
copyright = {2021 Springer Nature Limited},
issn = {1474-1784},
shorttitle = {Kinase drug discovery 20 years after imatinib},
url = {https://www.nature.com/articles/s41573-021-00195-4},
doi = {10.1038/s41573-021-00195-4},
abstract = {Protein kinases regulate nearly all aspects of cell life, and alterations in their expression, or mutations in their genes, cause cancer and other diseases. Here, we review the remarkable progress made over the past 20 years in improving the potency and specificity of small-molecule inhibitors of protein and lipid kinases, resulting in the approval of more than 70 new drugs since imatinib was approved in 2001. These compounds have had a significant impact on the way in which we now treat cancers and non-cancerous conditions. We discuss how the challenge of drug resistance to kinase inhibitors is being met and the future of kinase drug discovery.},
language = {en},
number = {7},
urldate = {2022-06-30},
journal = {Nature Reviews Drug Discovery},
author = {Cohen, Philip and Cross, Darren and Jänne, Pasi A.},
month = jul,
year = {2021},
note = {Number: 7
Publisher: Nature Publishing Group},
keywords = {Drug development, Drug discovery, Small molecules},
pages = {551--569},
}
Downloads: 0
{"_id":"9AEgEDDgeR8cmP9L2","bibbaseid":"cohen-cross-jnne-kinasedrugdiscovery20yearsafterimatinibprogressandfuturedirections-2021","author_short":["Cohen, P.","Cross, D.","Jänne, P. A."],"bibdata":{"bibtype":"article","type":"article","title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","copyright":"2021 Springer Nature Limited","issn":"1474-1784","shorttitle":"Kinase drug discovery 20 years after imatinib","url":"https://www.nature.com/articles/s41573-021-00195-4","doi":"10.1038/s41573-021-00195-4","abstract":"Protein kinases regulate nearly all aspects of cell life, and alterations in their expression, or mutations in their genes, cause cancer and other diseases. Here, we review the remarkable progress made over the past 20 years in improving the potency and specificity of small-molecule inhibitors of protein and lipid kinases, resulting in the approval of more than 70 new drugs since imatinib was approved in 2001. These compounds have had a significant impact on the way in which we now treat cancers and non-cancerous conditions. We discuss how the challenge of drug resistance to kinase inhibitors is being met and the future of kinase drug discovery.","language":"en","number":"7","urldate":"2022-06-30","journal":"Nature Reviews Drug Discovery","author":[{"propositions":[],"lastnames":["Cohen"],"firstnames":["Philip"],"suffixes":[]},{"propositions":[],"lastnames":["Cross"],"firstnames":["Darren"],"suffixes":[]},{"propositions":[],"lastnames":["Jänne"],"firstnames":["Pasi","A."],"suffixes":[]}],"month":"July","year":"2021","note":"Number: 7 Publisher: Nature Publishing Group","keywords":"Drug development, Drug discovery, Small molecules","pages":"551–569","bibtex":"@article{cohen_kinase_2021,\n\ttitle = {Kinase drug discovery 20 years after imatinib: progress and future directions},\n\tvolume = {20},\n\tcopyright = {2021 Springer Nature Limited},\n\tissn = {1474-1784},\n\tshorttitle = {Kinase drug discovery 20 years after imatinib},\n\turl = {https://www.nature.com/articles/s41573-021-00195-4},\n\tdoi = {10.1038/s41573-021-00195-4},\n\tabstract = {Protein kinases regulate nearly all aspects of cell life, and alterations in their expression, or mutations in their genes, cause cancer and other diseases. Here, we review the remarkable progress made over the past 20 years in improving the potency and specificity of small-molecule inhibitors of protein and lipid kinases, resulting in the approval of more than 70 new drugs since imatinib was approved in 2001. These compounds have had a significant impact on the way in which we now treat cancers and non-cancerous conditions. We discuss how the challenge of drug resistance to kinase inhibitors is being met and the future of kinase drug discovery.},\n\tlanguage = {en},\n\tnumber = {7},\n\turldate = {2022-06-30},\n\tjournal = {Nature Reviews Drug Discovery},\n\tauthor = {Cohen, Philip and Cross, Darren and Jänne, Pasi A.},\n\tmonth = jul,\n\tyear = {2021},\n\tnote = {Number: 7\nPublisher: Nature Publishing Group},\n\tkeywords = {Drug development, Drug discovery, Small molecules},\n\tpages = {551--569},\n}\n\n","author_short":["Cohen, P.","Cross, D.","Jänne, P. A."],"key":"cohen_kinase_2021","id":"cohen_kinase_2021","bibbaseid":"cohen-cross-jnne-kinasedrugdiscovery20yearsafterimatinibprogressandfuturedirections-2021","role":"author","urls":{"Paper":"https://www.nature.com/articles/s41573-021-00195-4"},"keyword":["Drug development","Drug discovery","Small molecules"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/qingyuhms","dataSources":["uJZG8wcPfTAfBw67Z"],"keywords":["drug development","drug discovery","small molecules"],"search_terms":["kinase","drug","discovery","years","imatinib","progress","future","directions","cohen","cross","jänne"],"title":"Kinase drug discovery 20 years after imatinib: progress and future directions","year":2021}